Clinical Trial Update: Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase I trial tested vandetanib in combination with capecitabine, oxaliplatin and bevacizumab for metastatic colorectal cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Vandetanib (vandetanib)

Snippet

Sponsor: Branimir Sikic | Conditions: Anal, Colon, and Rectal Cancers, Colorectal Neoplasms | Phase 1 | Status: COMPLETED